Jinesh Mehta MD
Critical Care Medicine, Interstitial Lung Diseases, Pleural Disease, Pulmonary Vascular Medicine
Division Chair Pulmonary Critical Care Florida Market
Join to view full profile
2950 Cleveland Clinic BlvdPulmonary MedicineWeston, FL 33331
Phone+1 954-659-5450
Fax+1 954-659-5451
Dr. Mehta is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jinesh Mehta is a pulmonologist in Weston, FL and is affiliated with Cleveland Clinic Florida. He received his medical degree from Seth G.S. Medical College and has been in practice 18 years. He also speaks multiple languages, including Gujarati and Hindi. He specializes in critical care medicine, interstitial lung diseases, pleural disease, and pulmonary vascular medicine and is experienced in pulmonary hypertension, asthma, chronic obstructive pulmonary disease, interstitial lung disease, and chronic obstructive bronchitis.
Education & Training
University of Louisville School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2008
Harlem Hospital CenterResidency, Internal Medicine, 2001 - 2004
Seth G.S. Medical CollegeClass of 1999
Certifications & Licensure
FL State Medical License 2011 - 2027
KY State Medical License 2004 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
Clinical Trials
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
- An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
- Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
Publications & Presentations
PubMed
- CLO26-097: Robotic-Assisted Bronchoscopy (RAB) Compared to CT-Guided Transthoracic Biopsy (CTTB) in the Diagnosis of Lung Malignancy.Theresa Abdo, Ahmad Alhalabi, Kaylee Sarna, John Woytanowski, Ivan Romero-Legro
Journal of the National Comprehensive Cancer Network. 2026-03-31 - 1 citationsCLO26-097: Robotic-Assisted Bronchoscopy (RAB) Compared to CT-Guided Transthoracic Biopsy (CTTB) in the Diagnosis of Lung Malignancy.Theresa Abdo, Ahmad Alhalabi, Kaylee Sarna, John Woytanowski, Ivan Romero-Legro
Journal of the National Comprehensive Cancer Network. 2026-03-31 - 6 citationsBREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.Sandeep Sahay, Harold Palevsky, Karim El-Kersh, Ricardo Restrepo-Jaramillo, Abubakr A Bajwa
Respiratory Medicine. 2025-11-01
Journal Articles
- Granulomatous‐Lymphocytic Interstitial Lung Disease as the First Manifestation of Common Variable ImmunodeficiencyRoya Memarpour, Pablo Bejarano, Jose Ramirez, Jinesh Mehta, The Clinical Respiratory Journal
Professional Memberships
- Member
- Member
Other Languages
- Gujarati, Hindi
External Links
- Websitehttp://my.clevelandclinic.org/staff_directory/staff_display.aspx?DoctorID=16573
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
